Menarini inaugurates its China headquarters in Wuhan Biolake

Family-owned Menarini Group, Italy’s largest biopharma company, has officially launched its China headquarters at the Wuhan National Bioindustry Base (Wuhan Biolake) in Hubei Province.

Menarini says the inauguration of the China headquarters was a key milestone for the company, signifying Menarini’s enhanced presence in the world’s most dynamic market.

“Menarini is rapidly accelerating its growth in the Asia-Pacific region and our growth strategy and China is pivotal to the overall plan. The establishment of Menarini China headquarters as the first wholly-owned foreign pharmaceutical holding company in Wuhan Biolake is therefore a key and vital milestone in the history of Menarini. It is a major leap for us to demonstrate our long-term commitment to help improve the health of Chinese patients and to invest in the world’s fastest growing healthcare market,” said Pietro Giovanni Corsa, general manager of the Menarini Group.